乳腺x线摄影乳腺面积/微钙化簇面积(BA/MCA)比值在BI-RADS 4病变分类中的作用:乳腺癌患者人工智能发展的一步

IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Ibrahim Burak Bahçecioğlu, Şevket Barış Morkavuk, Şebnem Çimen, Müjdat Turan, Gökay Çetinkaya, Mehmet Ali Gülçelik
{"title":"乳腺x线摄影乳腺面积/微钙化簇面积(BA/MCA)比值在BI-RADS 4病变分类中的作用:乳腺癌患者人工智能发展的一步","authors":"Ibrahim Burak Bahçecioğlu,&nbsp;Şevket Barış Morkavuk,&nbsp;Şebnem Çimen,&nbsp;Müjdat Turan,&nbsp;Gökay Çetinkaya,&nbsp;Mehmet Ali Gülçelik","doi":"10.1155/ijcp/3533205","DOIUrl":null,"url":null,"abstract":"<div>\n <p><b>Introduction:</b> The working principle of artificial intelligence in medicine is primarily as follows: The data are collected and entered into the system, the computer uses an algorithm to gather information via these data, and finally, it analyzes this algorithm to utilize in the diagnosis and treatment of the disease. In this study, we investigated the achievement of mammographic breast area/microcalcification cluster area ratio (BA/MCA) in the grouping of BI-RADS 4 (a, b, c) lesions. We planned to contribute to the development of artificial intelligence in medicine with a simple calculation program to be attached to the mammography computer.</p>\n <p><b>Methods:</b> 125 patients who underwent surgery with the diagnosis of mammographic BI-RADS 4 lesion (could not be detected in lesion-specific ultrasonography) between 2019 and 2022 in the Department of Surgical Oncology of Health Sciences University Gulhane Medical Faculty Training and Research Hospital were retrospectively examined. The mammographic MCA was divided by the breast area and their ratio was calculated. The relationship between the ratios we found and the BI-RADS values defined by radiology was analyzed.</p>\n <p><b>Results:</b> We found the median BA/MCA value of BI-RADS 4a patients to be 24943.5, BI-RADS 4b patients to be 12609.2, and BI-RADS 4c patients to be 11547.1 (<i>p</i> = 0.003). According to ROC curve analysis, we detected the BA/MCA ratio for BI-RADS 4c to be 14183.34 (AUC = 0.686, <i>p</i> = 0.005, sensitivity 54.2%). This ratio is inversely related, and the probability of BI-RADS 4c increases in patients with a BA/MCA ratio less than 14183.34. We revealed that the malignancy rate of radiological BI-RADS 4c patients was 90%, and the cutoff value of BI-RADS 4c patients was 72%. Using both classifications together, we detected the malignancy rate to be 98%.</p>\n <p><b>Conclusion:</b> The increase in the ratio of MCA to BA might have a place in the differentiation of BI-RADS 4 lesions. We foresee that artificial intelligence could also have a place in the classification of BI-RADS lesions with software to be installed on the mammography computer.</p>\n </div>","PeriodicalId":13782,"journal":{"name":"International Journal of Clinical Practice","volume":"2024 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/3533205","citationCount":"0","resultStr":"{\"title\":\"The Role of Mammographic Breast Area/Microcalcification Cluster Area (BA/MCA) Ratio in the Classification of BI-RADS 4 Lesions: A Step for Development of Artificial Intelligence in Breast Cancer Patients\",\"authors\":\"Ibrahim Burak Bahçecioğlu,&nbsp;Şevket Barış Morkavuk,&nbsp;Şebnem Çimen,&nbsp;Müjdat Turan,&nbsp;Gökay Çetinkaya,&nbsp;Mehmet Ali Gülçelik\",\"doi\":\"10.1155/ijcp/3533205\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n <p><b>Introduction:</b> The working principle of artificial intelligence in medicine is primarily as follows: The data are collected and entered into the system, the computer uses an algorithm to gather information via these data, and finally, it analyzes this algorithm to utilize in the diagnosis and treatment of the disease. In this study, we investigated the achievement of mammographic breast area/microcalcification cluster area ratio (BA/MCA) in the grouping of BI-RADS 4 (a, b, c) lesions. We planned to contribute to the development of artificial intelligence in medicine with a simple calculation program to be attached to the mammography computer.</p>\\n <p><b>Methods:</b> 125 patients who underwent surgery with the diagnosis of mammographic BI-RADS 4 lesion (could not be detected in lesion-specific ultrasonography) between 2019 and 2022 in the Department of Surgical Oncology of Health Sciences University Gulhane Medical Faculty Training and Research Hospital were retrospectively examined. The mammographic MCA was divided by the breast area and their ratio was calculated. The relationship between the ratios we found and the BI-RADS values defined by radiology was analyzed.</p>\\n <p><b>Results:</b> We found the median BA/MCA value of BI-RADS 4a patients to be 24943.5, BI-RADS 4b patients to be 12609.2, and BI-RADS 4c patients to be 11547.1 (<i>p</i> = 0.003). According to ROC curve analysis, we detected the BA/MCA ratio for BI-RADS 4c to be 14183.34 (AUC = 0.686, <i>p</i> = 0.005, sensitivity 54.2%). This ratio is inversely related, and the probability of BI-RADS 4c increases in patients with a BA/MCA ratio less than 14183.34. We revealed that the malignancy rate of radiological BI-RADS 4c patients was 90%, and the cutoff value of BI-RADS 4c patients was 72%. Using both classifications together, we detected the malignancy rate to be 98%.</p>\\n <p><b>Conclusion:</b> The increase in the ratio of MCA to BA might have a place in the differentiation of BI-RADS 4 lesions. We foresee that artificial intelligence could also have a place in the classification of BI-RADS lesions with software to be installed on the mammography computer.</p>\\n </div>\",\"PeriodicalId\":13782,\"journal\":{\"name\":\"International Journal of Clinical Practice\",\"volume\":\"2024 1\",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/3533205\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/ijcp/3533205\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ijcp/3533205","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

人工智能在医学中的工作原理主要是这样的:收集数据并输入系统,计算机通过这些数据使用一种算法来收集信息,最后对该算法进行分析,用于疾病的诊断和治疗。在本研究中,我们研究了乳腺x线摄影的乳房面积/微钙化簇面积比(BA/MCA)在BI-RADS 4 (a, b, c)病变分组中的实现情况。我们计划通过将一个简单的计算程序附加到乳房x光检查计算机上,为医学中人工智能的发展做出贡献。方法:回顾性分析健康科学大学Gulhane医学院培训与研究医院外科肿瘤科2019 - 2022年诊断为乳腺x线BI-RADS 4病变(病变特异性超声检查未发现)的125例手术患者。乳房x线摄影MCA除以乳房面积并计算其比值。分析了我们发现的比率与放射学定义的BI-RADS值之间的关系。结果:BI-RADS 4a患者BA/MCA中位数为24943.5,BI-RADS 4b患者BA/MCA中位数为12609.2,BI-RADS 4c患者BA/MCA中位数为11547.1 (p = 0.003)。根据ROC曲线分析,我们检测到BI-RADS 4c的BA/MCA比值为14183.34 (AUC = 0.686, p = 0.005,灵敏度为54.2%)。该比值呈负相关,BA/MCA比值小于14183.34的患者BI-RADS 4c的概率增加。我们发现放射学BI-RADS 4c患者的恶性率为90%,BI-RADS 4c患者的临界值为72%。结合两种分类,我们检测到恶性肿瘤的发生率为98%。结论:MCA / BA比值的升高可能与BI-RADS 4型病变的分化有关。我们预计,人工智能也可以在BI-RADS病变的分类中占有一席之地,软件将安装在乳房x光检查计算机上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Role of Mammographic Breast Area/Microcalcification Cluster Area (BA/MCA) Ratio in the Classification of BI-RADS 4 Lesions: A Step for Development of Artificial Intelligence in Breast Cancer Patients

The Role of Mammographic Breast Area/Microcalcification Cluster Area (BA/MCA) Ratio in the Classification of BI-RADS 4 Lesions: A Step for Development of Artificial Intelligence in Breast Cancer Patients

Introduction: The working principle of artificial intelligence in medicine is primarily as follows: The data are collected and entered into the system, the computer uses an algorithm to gather information via these data, and finally, it analyzes this algorithm to utilize in the diagnosis and treatment of the disease. In this study, we investigated the achievement of mammographic breast area/microcalcification cluster area ratio (BA/MCA) in the grouping of BI-RADS 4 (a, b, c) lesions. We planned to contribute to the development of artificial intelligence in medicine with a simple calculation program to be attached to the mammography computer.

Methods: 125 patients who underwent surgery with the diagnosis of mammographic BI-RADS 4 lesion (could not be detected in lesion-specific ultrasonography) between 2019 and 2022 in the Department of Surgical Oncology of Health Sciences University Gulhane Medical Faculty Training and Research Hospital were retrospectively examined. The mammographic MCA was divided by the breast area and their ratio was calculated. The relationship between the ratios we found and the BI-RADS values defined by radiology was analyzed.

Results: We found the median BA/MCA value of BI-RADS 4a patients to be 24943.5, BI-RADS 4b patients to be 12609.2, and BI-RADS 4c patients to be 11547.1 (p = 0.003). According to ROC curve analysis, we detected the BA/MCA ratio for BI-RADS 4c to be 14183.34 (AUC = 0.686, p = 0.005, sensitivity 54.2%). This ratio is inversely related, and the probability of BI-RADS 4c increases in patients with a BA/MCA ratio less than 14183.34. We revealed that the malignancy rate of radiological BI-RADS 4c patients was 90%, and the cutoff value of BI-RADS 4c patients was 72%. Using both classifications together, we detected the malignancy rate to be 98%.

Conclusion: The increase in the ratio of MCA to BA might have a place in the differentiation of BI-RADS 4 lesions. We foresee that artificial intelligence could also have a place in the classification of BI-RADS lesions with software to be installed on the mammography computer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.30
自引率
0.00%
发文量
274
审稿时长
3-8 weeks
期刊介绍: IJCP is a general medical journal. IJCP gives special priority to work that has international appeal. IJCP publishes: Editorials. IJCP Editorials are commissioned. [Peer reviewed at the editor''s discretion] Perspectives. Most IJCP Perspectives are commissioned. Example. [Peer reviewed at the editor''s discretion] Study design and interpretation. Example. [Always peer reviewed] Original data from clinical investigations. In particular: Primary research papers from RCTs, observational studies, epidemiological studies; pre-specified sub-analyses; pooled analyses. [Always peer reviewed] Meta-analyses. [Always peer reviewed] Systematic reviews. From October 2009, special priority will be given to systematic reviews. [Always peer reviewed] Non-systematic/narrative reviews. From October 2009, reviews that are not systematic will be considered only if they include a discrete Methods section that must explicitly describe the authors'' approach. Special priority will, however, be given to systematic reviews. [Always peer reviewed] ''How to…'' papers. Example. [Always peer reviewed] Consensus statements. [Always peer reviewed] Short reports. [Always peer reviewed] Letters. [Peer reviewed at the editor''s discretion] International scope IJCP publishes work from investigators globally. Around 30% of IJCP articles list an author from the UK. Around 30% of IJCP articles list an author from the USA or Canada. Around 45% of IJCP articles list an author from a European country that is not the UK. Around 15% of articles published in IJCP list an author from a country in the Asia-Pacific region.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信